Best Hospitals for Vasculitis treatment in Italy 2026

San Raffaele Research Hospital in Milan and Careggi University Hospital in Florence specialize in complex vasculitis. These IRCCS-accredited centers combine clinical research with advanced rheumatology. Italian facilities often serve as hubs within the European Reference Network (ERN RITA). This ensures standardized care for rare autoimmune diseases.

• San Raffaele hospital: Offers expert care for rare immune system and genetic diseases.
• Careggi university hospital: Features a dedicated Reference Center for Systemic Autoimmune Diseases.
• San Giovanni Bosco: Serves as a multidisciplinary hub for immunopathology and rare diseases.
• Specialized diagnostic methods: Hospitals utilize advanced vascular imaging and quick biopsies for diagnosis.

Bookimed Expert Insight: San Raffaele stands out by performing over 52,000 operations annually. It is one of Europe’s largest research hospitals. Most general hospitals lack this scale and IRCCS research status. Choosing an IRCCS-accredited facility ensures access to clinical trials for complex cases. These centers often have more experience with rare vasculitis variants.

Patient Consensus: Patients note that university-affiliated hospitals in Pavia and Padua provide faster specialist care. Many recommend booking directly with experts to avoid long emergency room waits.

Italian specialists treat vasculitis using a combination of high-dose glucocorticoids and targeted biologics. Prednisone serves as the primary first-line therapy to manage acute inflammation. Doctors often combine it with Rituximab or Cyclophosphamide to induce remission safely and prevent disease relapse.

• Induction therapy: High-dose pulse Methylprednisolone or Prednisone rapidly controls severe systemic inflammation.
• Biologic agents: Rituximab is frequently preferred over traditional drugs to minimize long-term infertility risks.
• Maintenance medications: Methotrexate and Azathioprine sustain remission once the initial inflammatory phase subsides.
• Targeted treatments: Tocilizumab and Mepolizumab treat specific types like Giant Cell Arteritis or EGPA.

Bookimed Expert Insight: Data from major Italian research hospitals like San Raffaele in Milan shows a shift toward steroid-sparing protocols. These centers integrate Avacopan and early biologics to reduce classic steroid-related side effects like diabetes. Academic institutions in Northern Italy often provide faster access to these emerging complement inhibitors via clinical research trials.

Patient Consensus: Patients note that specialists in Northern Italy prioritize frequent blood monitoring and PET scans to taper steroids quickly. Many suggest confirming drug coverage through the national health system early in the process.

Coverage for vasculitis treatment in Italy depends on your residency and citizenship status. European Union citizens using a European Health Insurance Card receive care under the same terms as local residents. Non-EU visitors generally pay out-of-pocket unless they hold an Italian residency permit.

• EU citizens: Use the European Health Insurance Card for medically necessary specialist care.
• Legal residents: Register with the Servizio Sanitario Nazionale to access covered chronic treatments.
• Rare disease status: Residents with GPA or MPA may receive specific cost exemption codes.
• Private patients: Non-EU foreigners typically require private insurance for elective infusion therapies.

Bookimed Expert Insight: San Raffaele in Milan is a key destination for complex cases. It is one of the few centers with IRCCS accreditation for immune research. This status means they combine clinical care with advanced research activities. For non-resident patients, these institutions often offer lower public rates compared to private hospitals. Always verify if your specific diagnosis qualifies for Italian rare disease exemptions before starting long-term care.

Patient Consensus: Patients note that emergency care is always available regardless of status. Many suggest securing an elective residency visa for long-term treatment to access public health benefits.

Discuss the specific type of vasculitis with your specialist to align with Italian Society of Rheumatology guidelines. Review organ involvement and the necessity of biologic therapies like rituximab for remission. Confirm screening protocols for chronic infections required before starting immunosuppressive treatments in Italian hospitals.

• Treatment guidelines: Confirm if your plan follows SIRT recommendations for large-vessel vasculitis.
• Organ assessment: Discuss current damage to critical organs like kidneys or lungs.
• Biologic therapy: Inquire about using rituximab or tocilizumab for long-term maintenance.
• Screening requirements: Discuss mandatory tuberculosis testing before beginning any biologic infusion cycles.

Bookimed Expert Insight: San Raffaele in Milan serves as a major hub for rare immune diseases. It combines clinical care with research through its IRCCS accreditation. For complex vasculitis cases, this hospital performs over 52,000 operations annually. Patients benefit from the multidisciplinary approach used at large research centers. This ensures rheumatology and nephrology experts co-manage systemic organ involvement effectively.

Patient Consensus: Patients highlight that investing in a private initial visit can reduce wait times from months to weeks. Confirming the specific administrative code for your condition is vital to ensure full medication coverage.